Enrofloxacin

Spezifikationen

93106-60-6CAS-Nummer

618-911-2EG-Nummer

1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acidIUPAC-Name

C19H22FN3O3Chemische Formel

359.4 g/molMolekulargewicht

Enrofloxacin; 93106-60-6; Baytril; Enrofloxacine; Enrofloxacino; BAY VP 2674; Enrofloxacinum; endrofloxicin; Bay-Vp-2674; DTXSID1045619; 3DX3XEK1BN; NSC-758616; Enrofloxacin for veterinary use; 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-; CHEBI:35720; DTXCID9025619; 3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-; Enrofloxacin base; Quellaxcin; Enroflox; Enroquin; Enrosite; Fluroxin; Tenotryl; SolutionKits; Zobuxa; EnroMed; Enroquin Flavored; Enrosite Flavored; Fluroxin Flavored; Enroflox 100; Enrofloxacin Flavored; EnroMed 100; EnroPro 100; EnroPro 22.7; RefChem:55095; SolutionKits Enrofloxacin; Enroflox Chewable Tablets; ENROFLOXACIN 100; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-Fluoro-1,4-Dihydro-4-Oxo-3-Quinolonecarboxylic Acid; Fluroxin for Dogs 2.27%; Enrofloxacin Flavored Tablets; Baytril Soft Chewable Tablets; Baytril 100 Injectable Solution; Enroflox Injection for Dogs 2.27%; Baytril Antibacterial Injectable Solution; Enrofloxacin Antibacterial Injectable Solution; Baytril Antibacterial Tablets, Baytril Taste Tabs Antibacterial Tablets; Enrofloxacin HCl; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; CFPQ; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; MFCD00792463; N-Ethylciprofloxacin; Enroxil; Baytril (TN); ERFX; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid; MLS000069441; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-quinoline-3-carboxylic acid; BAY Vp 2674;PD160788; NCGC00018143-04; CPD000059011; SMR000059011; Enrofloxacine [French]; Enrofloxacinum [Latin]; Enrofloxacino [Spanish]; 1-cyclopropyl-7-(4-ethylpiperazinyl)-6-fluoro-4-oxohydroquinoline-3-carboxylic acid; CAS-93106-60-6; Enrofloxacin [USAN:BAN:INN]; HSDB 6952; UNII-3DX3XEK1BN; BRN 5307824; CCRIS 8214; Enrofloxacin CRS; Enrofloxacin [USAN:USP:INN:BAN]; Baytril (veterinary); Enrofloxacin (Standard); Opera_ID_1106; Enrofloxacin (USP/INN); ENROFLOXACIN [MI]; Enrofloxacin (USAN/INN); ENROFLOXACIN [INN]; Epitope ID:540295; ENROFLOXACIN [HSDB]; ENROFLOXACIN [USAN]; 1,4-Dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid; ENROFLOXACIN [MART.]; MLS001076496; MLS001424169; CHEMBL15511; ENROFLOXACIN [USP-RS]; SCHEMBL149150; SPECTRUM1503721; orb1307995; orb3139616; SCHEMBL29349852; GTPL13668; HY-B0502R; ENROFLOXACIN [GREEN BOOK]; MSK4107; HMS2052O09; HMS2090E12; HMS2093I21; HMS2234M11; HMS3373P14; HMS3394O09; HMS3715B18; HMS5087O14; Pharmakon1600-01503721; ENROFLOXACIN [USP IMPURITY]; MSK4107-100DM; ALBB-030792; HY-B0502; ENROFLOXACIN [USP MONOGRAPH]; Enrofloxacin, >=98.0% (HPLC); MSK4107-1000DM; Tox21_110831; BBL009982; DL-384; MSK4107-100A; MSK4107-100M; NSC758616; s3059; SBB012586; STK711109; AKOS005530685; BAY-Vp2674;PD160788; Tox21_110831_1; AC-7614; AE22674; CCG-101102; DB11404; EBC-429044; Enrofloxacin for system suitability CRS; KS-5010; NC00352; NSC 758616; NCGC00018143-01; NCGC00018143-02; NCGC00018143-03; NCGC00018143-05; NCGC00021632-03; PD160788; ST072197; SY052755; SBI-0206725.P001; DB-057368; E0786; E5369; Enrofloxacin 1000 microg/mL in Acetonitrile; Enrofloxacin Solution in Methanol, 100ug/mL; NS00010889; D02473; F81544; AB00384269-16; AB00384269_17; AB00384269_18; Enrofloxacin Solution in Acetonitrile, 100ug/mL; Enrofloxacin, VETRANAL(TM), analytical standard; Enrofloxacin Solution in DMSO/Methanol, 100ug/mL; F862494; Q414413; SR-01000000045; Enrofloxacin Solution in DMSO/Methanol, 1000ug/mL; SR-01000000045-3; BRD-K76534306-001-11-0; BRD-K76534306-001-21-9; BRD-K76534306-001-22-7; ENROFLOXACIN FOR VETERINARY USE [EP IMPURITY]; ENROFLOXACIN FOR VETERINARY USE [EP MONOGRAPH]; F2173-0641; 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1; Enrofloxacin, European Pharmacopoeia (EP) Reference Standard; Enrofloxacin, United States Pharmacopeia (USP) Reference Standard; Enrofloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard; Enrofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinoline-carboxylic acid; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinolinecarboxylic acid; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3- quinolonecarboxylic acid; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 9CI; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid; 1-CYCLOPROPYL-7-(4-ETHYLPIPERAZINO)-6-FLUORO-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXYLIC ACID; Baytril; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acidSynonyme